AllSight
Companies · CAH · Wholesale-Drugs, Proprietaries & Druggists' Sundries

CARDINAL HEALTH INC (CAH)

CARDINAL HEALTH INC (CAH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

CARDINAL HEALTH INC (CAH) stock — financials & valuation

Key numbers for CARDINAL HEALTH INC (CAH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 59/100 — a percentile rank of CARDINAL HEALTH INC’s fundamentals against Wholesale peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$51.5B
P / E30.1×
P / S0.2×
EV / EBITDA14.5×
Gross margin3.8%
Operating margin1.1%
Net margin0.7%
Return on equity-59.5%
ROIC168.4%
Revenue growth14.2%
Debt / equity-3.1×
Dividend yield0.9%

Is CARDINAL HEALTH INC overvalued? P/E looks fair vs its 5-year range; P/S looks overvalued vs its 5-year range; EV/EBITDA looks overvalued vs its 5-year range.

Independent of the events above — derived from CARDINAL HEALTH INC’s own financial statements and shown as context, never as advice.

Aug 11, 2026
Underlying EPS beat and FY27 guide topped estimates despite a revenue miss
Aug 11, 2026
Cardinal replaces $4 billion of credit facilities with one longer-dated revolver
Aug 5, 2026
Appoints Baxter’s interim CFO as next chief accounting officer
Related companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact